ACP
NVS icon

Aviance Capital Partners’s Novartis NVS Stock Holding History

Aviance Capital Partners’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,313
Closed -$201K – 232
2019
Q3 		$201K Buy
+2,313
New +$208K 0.06% 210

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Aviance Capital Partners's NVS Position: Q4 2019 in Review

Aviance Capital Partners sold out of Novartis (NVS) in Q4 2019, closing a stake of 2,313 shares — an estimated $201K sold.

Aviance Capital Partners first reported a position in NVS in Q3 2019 and held it in 1 quarter. The position peaked at $201K in Q3 2019. 1,172 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

  • Aviance Capital Partners reported no remaining Novartis position as of Q4 2019 after selling out during the quarter.
  • Aviance Capital Partners sold 2,313 Novartis shares in Q4 2019, an estimated $201K.
  • Aviance Capital Partners first reported a position in Novartis in Q3 2019 and held it in 1 quarter.
  • Aviance Capital Partners's Novartis position peaked at $201K in Q3 2019.
  • 1,172 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Aviance Capital Partners's 13F filing for Q4 2019, filed 7 Feb 2020.